Citation: Jj. Liu et al., CREATINE-KINASE RELEASE AFTER HEPATIC-ARTERY EMBOLIZATION IN PATIENTSWITH CARCINOID-TUMORS, Cancer investigation, 16(3), 1998, pp. 211-211
Authors:
AABO K
ADAMS M
ADNITT P
ALBERTS DS
ATHANAZZIOU A
BARLEY V
BELL DR
BIANCHI U
BOLIS G
BRADY MF
BRODOVSKY HS
BRUCKNER H
BUYSE M
CANETTA R
CHYLAK V
COHEN CJ
COLOMBO N
CONTE PF
CROWTHER D
EDMONSON JH
GENNATAS C
GILBEY E
GORE M
GUTHRIE D
KAYE SB
LAING AH
LANDONI F
LEONARD RC
LEWIS C
LIU PY
MANGIONI C
MARSONI S
MEERPOHL H
OMURA GA
PARMAR MKB
PATER J
PECORELLI S
PRESTI M
SAUERBREI W
SKARLOS DV
SMALLEY RV
SOLOMON HJ
STEWART LA
STURGEON JFG
TATTERSALL MHN
WHARTON JT
HUININK WWT
TOMIROTTI M
TORRI W
TROPE C
TURBOW MM
VERMORKEN JB
WEBB MJ
WILBUR DW
WILLIAMS CJ
WILTSHAW E
YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
Authors:
EDMONSON JH
LONG HJ
KVOLS LK
MANN BS
GRILL JP
Citation: Jh. Edmonson et al., CAN MOLGRAMOSTIM ENHANCE THE ANTITUMOR EFFECTS OF CYTOTOXIC DRUGS IN PATIENTS WITH ADVANCED SARCOMAS, Annals of oncology, 8(7), 1997, pp. 637-641
Authors:
TIERNEY JF
STEWART LA
PARMAR MKB
FLETCHER CDM
JONES G
MOSSERI V
PATEL M
DEELVIRA MCR
SOUHAMI RL
SYLVESTER R
TURSZ T
ALVEGARD TA
SIGURDSSON H
ANTMAN K
BACCHI M
BAKER LH
BENJAMIN RS
BRADY MF
BRAMWELL V
BUI BN
EDMONSON JH
LEYVRAZ S
OMURA GA
ROUESSE J
RYAN L
VANOOSTEROM AT
YANG JC
Citation: Jf. Tierney et al., ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA, Lancet, 350(9092), 1997, pp. 1647-1654
Authors:
EDMONSON JH
EBBERT LP
NASCIMENTO AG
JUNG SH
MCGAW H
GERSTNER JB
Citation: Jh. Edmonson et al., PHASE-II STUDY OF DOCETAXEL IN ADVANCED SOFT-TISSUE SARCOMAS, American journal of clinical oncology, 19(6), 1996, pp. 574-576
Authors:
ZANETTA G
KEENEY GL
CHA SS
FARR GH
KATZMANN JA
WIEAND HS
EDMONSON JH
PODRATZ KC
Citation: G. Zanetta et al., FLOW-CYTOMETRIC ANALYSIS OF DEOXYRIBONUCLEIC-ACID CONTENT IN ADVANCEDOVARIAN-CARCINOMA - ITS IMPORTANCE IN LONG-TERM SURVIVAL, American journal of obstetrics and gynecology, 175(5), 1996, pp. 1217-1225
Citation: Jh. Edmonson et al., CYTOTOXIC DRUGS PLUS SUBCUTANEOUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - CAN MOLGRAMOSTIM ENHANCE ANTISARCOMA THERAPY, Journal of the National Cancer Institute, 86(4), 1994, pp. 312-314
Authors:
HARTMANN LC
PODRATZ KC
KEENEY GL
KAMEL NA
EDMONSON JH
GRILL JP
SU JQ
KATZMANN JA
ROCHE PC
Citation: Lc. Hartmann et al., PROGNOSTIC-SIGNIFICANCE OF P53 IMMUNOSTAINING IN EPITHELIAL OVARIAN-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 64-69
Citation: V. Ganju et al., PHASE-I STUDY OF COMBINED ALPHA-INTERFERON, ALPHA-DIFLUOROMETHYLORNITHINE (DFMO), AND DOXORUBICIN IN ADVANCED MALIGNANCY, Investigational new drugs, 12(1), 1994, pp. 25-27
Authors:
CLEELAND CS
GONIN R
HATFIELD AK
EDMONSON JH
BLUM RH
STEWART JA
PANDYA KJ
Citation: Cs. Cleeland et al., PAIN AND ITS TREATMENT IN OUTPATIENTS WITH METASTATIC CANCER, The New England journal of medicine, 330(9), 1994, pp. 592-596
Citation: G. Colonotero et al., SECONDARY MYELODYSPLASIA AND ACUTE-LEUKEMIA FOLLOWING CARBOPLATIN-CONTAINING COMBINATION CHEMOTHERAPY FOR OVARIAN-CANCER, Journal of the National Cancer Institute, 85(22), 1993, pp. 1858-1860
Authors:
SAPHNER T
TROXEL AB
TORMEY DC
NEUBERG D
ROBERT NJ
PANDYA KJ
EDMONSON JH
ROSENBLUTH RJ
ABELOFF MD
Citation: T. Saphner et al., PHASE-II STUDY OF GOSERELIN FOR PATIENTS WITH POSTMENOPAUSAL METASTATIC BREAST-CANCER, Journal of clinical oncology, 11(8), 1993, pp. 1529-1535
Authors:
EDMONSON JH
RYAN LM
BLUM RH
BROOKS JSJ
SHIRAKI M
FRYTAK S
PARKINSON DR
Citation: Jh. Edmonson et al., RANDOMIZED COMPARISON OF DOXORUBICIN ALONE VERSUS IFOSFAMIDE PLUS DOXORUBICIN OR MITOMYCIN, DOXORUBICIN, AND CISPLATIN AGAINST ADVANCED SOFT-TISSUE SARCOMAS, Journal of clinical oncology, 11(7), 1993, pp. 1269-1275